These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 2432857)

  • 1. [Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic drug, on histamine release from monkey lung fragments].
    Takahashi K; Shono T
    Arerugi; 1986 Sep; 35(9):975-81. PubMed ID: 2432857
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic agent, on the release of mediators from guinea pig lung fragments.
    Takahashi K; Yamada N; Endoh K; Yasumura K
    Arerugi; 1986 Sep; 35(9):982-7. PubMed ID: 2432858
    [No Abstract]   [Full Text] [Related]  

  • 3. [Antiallergic effect of MY-5116 and its major metabolite, MY-1250].
    Kohno SW; Ohata K
    Arerugi; 1986 Nov; 35(11):1105-12. PubMed ID: 2435266
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of MY-1250, a main active metabolite of MY-5116, a new anti-allergic drug, on histamine release from rat peritoneal exudate cells and the degranulation of mesenteric mast cells].
    Takahashi K; Shono T; Arai Y
    Arerugi; 1986 Oct; 35(10):1028-36. PubMed ID: 2434065
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 4th communication: effects on histamine release from human leukocytes and from human and monkey lung fragments.
    Yanagihara Y; Abe T; Tsuriya Y; Kuroda T; Shida T
    Arzneimittelforschung; 1988 Jan; 38(1):84-7. PubMed ID: 2452641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of a major metabolite of the antiallergic drug repirinast on phosphodiesterase and adenylate cyclase activities.
    Yamada N; Arai Y; Funayama K; Kadowaki S; Takahashi K; Umezu K
    Arzneimittelforschung; 1995 Jan; 45(1):33-5. PubMed ID: 7534459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of immunological histamine release from guinea pig lungs and other organs by mepyramine, ketotifen, and picumast in vivo.
    Sekardi L; Friedberg KD
    Arzneimittelforschung; 1989 Oct; 39(10A):1331-5. PubMed ID: 2483312
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of histamine release from human lung in vitro by antihistamines and related drugs.
    Church MK; Gradidge CF
    Br J Pharmacol; 1980 Aug; 69(4):663-7. PubMed ID: 6159940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histamine H1 antagonists and histamine release from human lung in vitro [proceedings].
    Church MK; Gradidge CF
    Br J Pharmacol; 1979 May; 66(1):68P. PubMed ID: 88242
    [No Abstract]   [Full Text] [Related]  

  • 10. Antiallergic profile of the novel H1-antihistaminic compound levocabastine.
    Tasaka K; Kamei C; Akagi M; Mio M; Shirasaka T; Chokki M
    Arzneimittelforschung; 1993 Dec; 43(12):1331-7. PubMed ID: 7511378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-allergic activity of plant saponins in relation to their histamine releasing and anticholinesterase effects.
    Gupta SS
    Indian J Physiol Pharmacol; 1970 Apr; 14(2):95-101. PubMed ID: 4101516
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effects of MY-5116 on PCA reaction and on the histamine release from peritoneal cells induced by antigen antibody reactions].
    Takahashi K; Shono T
    Nihon Yakurigaku Zasshi; 1986 Jan; 87(1):29-39. PubMed ID: 2420688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition by azelastine of the immunologically induced histamine release from isolated guinea pig mast cells.
    Fischer B; Schmutzler W
    Arzneimittelforschung; 1981; 31(8):1193-5. PubMed ID: 6170297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reaginic antibody in experimental allergic encephalomyelitis. II. Histamine and serotonin blockade.
    Moore MJ; Matthews JM; Matthews TK; Behan PO; Kies MW
    Res Commun Chem Pathol Pharmacol; 1974 Sep; 9(1):133-44. PubMed ID: 4140560
    [No Abstract]   [Full Text] [Related]  

  • 15. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 2nd communication: inhibitory effects on histamine release from rat mast cells and lung fragments.
    Yanagihara Y; Abe T; Kuroda T; Shida T
    Arzneimittelforschung; 1988 Jan; 38(1):75-9. PubMed ID: 2452639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of H1 and H2 receptor blockers on immunological and nonspecific histamine release from isolated target cells.
    Hofman J; Siergiejko Z; Kuczewska B; Chyrek-Borowska S
    Arch Immunol Ther Exp (Warsz); 1984; 32(5):599-604. PubMed ID: 6085468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of two new histamine antagonists (BM 15,100 and BM 06,001) on bronchial muscle and histamine release from leucocytes.
    Assem ES; Chong EK
    Monogr Allergy; 1979; 14():310-2. PubMed ID: 91957
    [No Abstract]   [Full Text] [Related]  

  • 18. Regulation of the synthesis and release of slow-reacting substance of anaphylaxis from sensitized monkey lung.
    Weichman BM; Hostelley LS; Bostick SP; Muccitelli RM; Krell RD; Gleason JG
    J Pharmacol Exp Ther; 1982 May; 221(2):295-302. PubMed ID: 6176708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunopharmacological actions of the new antiallergic drug butyl 3'-(1H-tetrazol-5-yl)oxanilate. 3rd communication: inhibitory effects on histamine release from lung fragments, Schultz-Dale reaction in isolated tracheal muscle and experimental asthma in guinea pigs.
    Yanagihara Y; Abe T; Kuroda T; Shida T
    Arzneimittelforschung; 1988 Jan; 38(1):80-3. PubMed ID: 2452640
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunopharmacological studies of anti-hypersensitivity agents].
    Koda A
    Nihon Rinsho; 1981 Apr; 39(4):1801-6. PubMed ID: 6171654
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.